• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Rev Invest Clin . Development of Simple and Sensitive Score to Assess the Risk of Pneumonia in COVID-19 Patients

tetano

Editor, Senior Moderator
Rev Invest Clin


. 2020 Oct 19;73(5).
doi: 10.24875/RIC.20000295. Online ahead of print.
Development of Simple and Sensitive Score to Assess the Risk of Pneumonia in COVID-19 Patients


Macarena Hormanstorfer[SUP] 1 [/SUP], Martin A Ragusa[SUP] 1 [/SUP], Lucia Poggio[SUP] 1 [/SUP], Jorge Moreira-Facundo[SUP] 1 [/SUP], Zulma Orellana-Villa[SUP] 1 [/SUP], Florencia A Bobrowski[SUP] 1 [/SUP], Joaquin Martinez-Serventi[SUP] 1 [/SUP], Santiago N Piombi Adanza[SUP] 1 [/SUP], Jose A Enrique Barletta[SUP] 2 [/SUP], Alicia Sisto[SUP] 2 [/SUP], Hugo Delle-Piane[SUP] 1 [/SUP], Juan M Carrillo[SUP] 1 [/SUP], Jose L Presas[SUP] 1 [/SUP], Francisco Paulin[SUP] 1 [/SUP]



Affiliations

Abstract

Background: Severe pneumonia is the most common cause of intensive care unit (ICU) admission and death due to novel coronavirus (SARS-CoV-2) respiratory disease (COVID-19). Due to its rapid outbreak, units for the evaluation of febrile patients in the pre-hospital setting were created.
Objective: The objective of the study was to develop a sensitive and simple tool to assess the risk of pneumonia in COVID-19 patients and thus select which patients would require a chest imaging study.
Materials and methods: We conducted a cross-sectional study in a cohort of individuals with suspected COVID-19 evaluated in a public academic healthcare center in Buenos Aires city. All adult patients with positive RT-PCR assay for SARS-COV2 between April 24 and May 19 of 2020 were included in the study. Pneumonia was defined as the presence of compatible signs and symptoms with imaging confirmation. Univariate and multivariate logistic regression was performed. A risk indicator score was developed.
Results: One hundred and forty-eight patients were included, 71 (48%) received the diagnosis of pneumonia. The final clinical model included four variables: age >- 40 years, cough, absence of sore throat, and respiratory rate >- 22. To create the score, we assigned values to the variables according to their ORs: 2 points for respiratory rate >- 22 and 1 point to the other variables. The AUC of the ROC curve was 0.80 (CI 95% 0.73-0.86). A cutoff value of 2 showed a sensitivity of 95.7% and a specificity of 43.24%.
Conclusion: This sensible score may improve the risk stratification of COVID-19 patients in the pre-hospital setting.
 
Back
Top Bottom